Tissue engineering is an application whereby cells, engineering materials as well as biochemical elements are combined in order to enhance or restore damaged tissues and organs. This application is mainly used by doctors and more specifically surgeons but is also used by scientists and laboratories.
Tissue engineering market size was estimated at USD _43.7 million in 2022 and is forecast to reach USD _87.9 million by 2031, growing at a CAGR of _9.6%.
In recent times tissue engineering has seen a huge increase in demand due to patients opting for tissue engineering over surgeries, transplants and mechanical devices. There has also been an increase in demand due to the fact that people are looking for more regenerative treatments to diseases like obesity and diabetes.
Unfortunately, there are some problems with this increase in demand for tissue engineering. One of the main problems is there is a huge scarcity of tissue biopsy material as well as increasing difficulties surrounding cell expansion and the maintenance of phenotype. This means that scientists are unable to keep us with this growing demand making this a very expensive procedure and one that most can not unfortunately afford. Another problem is that due to the increase in demand there is a higher probability that majority of research and testing that needs to be done on base tissues is not done thoroughly enough and therefore hidden diseases or illnesses could pass by unnoticed.
Tissue engineering market Growth and Trends
The major factor contributing to the increase in the tissue engineering market growth is the rigorous development in the medical sector. Tissue engineering uses the concepts of both biology and engineering to restore, improvise, and maintain the function of the human tissue and this is a key factor driving the tissue engineering market. There has been a significant increase in the cost of traditional organ transplants and this facilitated the need for new, efficient, and cost-effective alternatives increasing tissue engineering market growth. Moreover, the use of 3D printing technology in medical procedures is said to accelerate the market demand and growth over the coming years. The tissue engineering technique is highly efficient and has less rejection ratio thus increasing the high market growth.
This technique is extensively used in gynaecology, dental, cardio, cancer, orthopaedic, and neurology department and a rising number of surgeries in the mentioned departments are a key factor contributing to the high market trend. Also, the rising number of replacement surgeries has necessitated the increase in the usage of tissue engineering thus promoting its market growth. An increase in the number of accidents and surge in the aged population is another major factor accelerating the tissue engineering market growth. An increase in government investments in medical research and development is also said to have a huge impact on the market revenue in the coming years.
However, the significantly high cost is a major limitation to the tissue engineering market growth along with the process being extremely tedious and time-consuming.
Segmentation Analysis
Tissue Engineering Market Competition
Key companies operating in this industry are Allergan, Integra LifesciencesC. R. Bard, Zimmer Biomet Organogenesis, Osiris Therapeutics, Cryolife, ACell, Biocomposites, DSM, Episkin, J-TEC, Athersys, Biotime, B. Braun, International Stem Cell and Bio Tissue Technologies.
Coverage Highlights
• Tissue Engineering Market Revenue Estimation and Forecast (2022 – 2031)
• Production Estimation and Forecast (2022 – 2031)
• Sales/Consumption Volume Estimation and Forecast (2022 – 2031)
• Breakdown of Revenue by Segments (2022 – 2031)
• Breakdown of Production by Segments (2022 – 2031)
• Breakdown of Sales Volume by Segments (2022 – 2031)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis
Tissue Engineering Market Segmentation
Product Outlook (Revenue, USD Million, 2022 - 2031)
• Synthetic Materials
• Biologically Derived Materials
Application Outlook (Revenue, USD Million, 2022 - 2031)
• Neurology
• Cardiology & Vascular
• Skin & Integumentary
• Others
Country (Revenue, USD Million, 2022 - 2031)
North America
• United States
• Canada
• Mexico
Asia-Pacific
• China
• Japan
• South Korea
• India
• Philippines
• Malaysia
• Australia
• Rest of Asia Pacific
Europe
• Italy
• Spain
• France
• UK
• Germany
• Belgium
• Netherlands
• Switzerland
• Russia
• Rest of Europe
South America
• Brazil
• Peru
• Chile
• Rest of South America
The Middle East and Africa
• Iran
• Israel
• Saudi Arabia
• Turkey
• Africa
Tissue Engineering Market Companies
• Allergan
• Integra Lifesciences
• C. R. Bard
• Zimmer Biomet
• Organogenesis
• Osiris Therapeutics
• Cryolife
• ACell
• Biocomposites
• DSM
• Episkin
• J-TEC
• Athersys
• Biotime
• B. Braun
• International Stem Cell
• Bio Tissue Technologies
Need Report on a particular Country OR need a Tailored/Customized Research? Budget Limits/Price Discounts Query...!
Email to David Correa
david@marketdecipher.com
OR Fill the below "Sample Request FORM" with your queries in the message box.
